Skip to main content
Top
Published in: European Journal of Nutrition 2/2007

01-12-2007 | SUPPLEMENT

Comparison of different nutrient profiling schemes to a new reference method using dietary surveys

Authors: Caroline Quinio, Anja Biltoft-Jensen, Stefaan De Henauw, Michael J. Gibney, Inge Huybrechts, Sinéad N. McCarthy, Jennifer L. O’Neill, Inge Tetens, Aida Turrini, Jean-Luc Volatier, ILSI Europe a.i.s.b.l.

Published in: European Journal of Nutrition | Special Issue 2/2007

Login to get access

Abstract

A new EU regulation on nutrition and health claims made on foods has entered into force in January 2007. The regulation provides for the use of nutrient profiles to determine which foods may bear claims but does not specify what the profiles should be or how they should be developed. Several nutrient profiling schemes have already been established. Therefore, it is necessary to develop approaches to test if the existing profiling schemes could fulfil the new regulation needs. The aim of the present study is to investigate how reference “indicator foods” derived from national dietary surveys in five different countries, are classified according to three existing nutrient profiling schemes: The UK Food Standards Agency (FSA) model, The Dutch Tripartite classification model and the US FDA model used for regulating health claims. “Indicator foods” that have been shown to be positively or negatively associated with healthy diets in adults in five EU countries were classified according to each of the three profiling schemes. The performance and effectiveness of each profiling scheme in correctly classifying the “indicator foods” were assessed using sensitivity and specificity ratios. The sensitivity and the specificity ratios of the three profiling schemes tested were relatively good. There were only small differences of performance between the three systems. A significant negative correlation between sensitivity and specificity was observed. The level of concordance between the classification of the “indicator foods” that have been selected because of being positively or negatively associated with a healthy diet and the classification by each of the three profiling methods tested was quite good. However, further improvement of the “indicator foods” approach is needed if it is to serve as a “gold standard”.
Literature
1.
go back to reference Volatier JL, Biltoft-Jensen A, De Henauw S, Gibney MJ, Huybrechts I, McCarthy SN, O’Neill JL, Quinio C, Turrini A, Tetens I (2007) A new reference method for the validation of the profiling schemes using dietary surveys. Eur J Nutr 46(Suppl 2):29–36CrossRef Volatier JL, Biltoft-Jensen A, De Henauw S, Gibney MJ, Huybrechts I, McCarthy SN, O’Neill JL, Quinio C, Turrini A, Tetens I (2007) A new reference method for the validation of the profiling schemes using dietary surveys. Eur J Nutr 46(Suppl 2):29–36CrossRef
2.
go back to reference Rayner M, Scarborough P, Boxer A and Stockley L (2005) Nutrient profiles: development of Final Model, December, British Heart Foundation Health Promotion Research Group. Department of Public Health, University of Oxford Rayner M, Scarborough P, Boxer A and Stockley L (2005) Nutrient profiles: development of Final Model, December, British Heart Foundation Health Promotion Research Group. Department of Public Health, University of Oxford
4.
go back to reference FDA (2002) Code of Federal Regulations, Title 21—Food and drugs (volume 2), Chapter I-Food and Drug Administration, Department of Health and Human Services, Part 101-Food Labeling-Table of Contents, Subpart A-General Provisions, Sec. 101.14 Health claims: general requirements and Subpart E-Specific requirements for Health Claims. U.S. Government Printing Office, Revised as of April 1 FDA (2002) Code of Federal Regulations, Title 21—Food and drugs (volume 2), Chapter I-Food and Drug Administration, Department of Health and Human Services, Part 101-Food Labeling-Table of Contents, Subpart A-General Provisions, Sec. 101.14 Health claims: general requirements and Subpart E-Specific requirements for Health Claims. U.S. Government Printing Office, Revised as of April 1
5.
go back to reference FDA (2002) Code of Federal Regulations, Title 21—Food and drugs (volume 2), Chapter I—Food and Drug Administration, Department of Health and Human Services, Part 101–Food Labeling-Table of Contents, Subpart A-General Provisions, Sec. 101.12 Reference amounts customarily consumed per eating occasion FDA (2002) Code of Federal Regulations, Title 21—Food and drugs (volume 2), Chapter I—Food and Drug Administration, Department of Health and Human Services, Part 101–Food Labeling-Table of Contents, Subpart A-General Provisions, Sec. 101.12 Reference amounts customarily consumed per eating occasion
Metadata
Title
Comparison of different nutrient profiling schemes to a new reference method using dietary surveys
Authors
Caroline Quinio
Anja Biltoft-Jensen
Stefaan De Henauw
Michael J. Gibney
Inge Huybrechts
Sinéad N. McCarthy
Jennifer L. O’Neill
Inge Tetens
Aida Turrini
Jean-Luc Volatier
ILSI Europe a.i.s.b.l.
Publication date
01-12-2007
Publisher
D. Steinkopff-Verlag
Published in
European Journal of Nutrition / Issue Special Issue 2/2007
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-007-2005-4

Other articles of this Special Issue 2/2007

European Journal of Nutrition 2/2007 Go to the issue

FOREWORD

Foreword

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine